Tenax Therapeutics (TENX) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.56% |
| Dec 31, 2025 | -2.86% |
| Sep 30, 2025 | -1.08% |
| Jun 30, 2025 | -1,023.85% |
| Mar 31, 2025 | -788.09% |
| Dec 31, 2024 | -868.66% |
| Sep 30, 2024 | -782.41% |
| Jun 30, 2024 | 29.94% |
| Mar 31, 2024 | 12.94% |
| Dec 31, 2023 | -361.02% |
| Sep 30, 2023 | -192.69% |
| Jun 30, 2023 | -85.27% |
| Mar 31, 2023 | -397.06% |
| Dec 31, 2022 | 61.96% |
| Sep 30, 2022 | 54.44% |
| Jun 30, 2022 | -231.25% |
| Mar 31, 2022 | 28.07% |
| Dec 31, 2021 | 16.82% |
| Sep 30, 2021 | 4.07% |
| Jun 30, 2021 | 52.07% |
| Mar 31, 2021 | 17.00% |
| Dec 31, 2020 | -24.32% |
| Sep 30, 2020 | -22.18% |
| Jun 30, 2020 | 48.89% |
| Mar 31, 2020 | 55.12% |
| Dec 31, 2019 | 58.02% |
| Sep 30, 2019 | -46.77% |
| Jun 30, 2019 | -39.05% |
| Mar 31, 2019 | -63.56% |
| Dec 31, 2018 | -66.45% |
| Sep 30, 2018 | 43.10% |
| Jun 30, 2018 | 27.16% |
| Mar 31, 2018 | 47.16% |
| Dec 31, 2017 | 41.82% |
| Sep 30, 2017 | -14.13% |
| Jun 30, 2017 | 11.61% |
| Mar 31, 2017 | -283.87% |
| Dec 31, 2016 | 34.22% |
| Sep 30, 2016 | -139.96% |
| Jun 30, 2016 | -48.81% |
| Apr 30, 2015 | 86.41% |
| Apr 30, 2014 | -7,343.33% |
| Apr 30, 2013 | 58.32% |
| Jan 31, 2013 | 74.74% |
| Oct 31, 2012 | 24.58% |
| Jul 31, 2012 | 32.69% |
| Apr 30, 2012 | -97.48% |
| Jan 31, 2012 | -528.23% |
| Oct 31, 2011 | -139.41% |
| Jul 31, 2011 | -46.36% |